Literature DB >> 15798544

[Medical and socio-economical impact of drug-induced adverse reactions].

Edwige Apretna1, Françoise Haramburu, Florence Taboulet, Bernard Bégaud.   

Abstract

OBJECTIVE: To analyse the nature of adverse drug reactions, their frequency, the drugs incriminated, their outcome, the different ways to treat them and their cost.
METHODS: Descriptive, prospective and non-comparative study, based on spontaneous reporting. Each patient was followed-up over a 6-month period.
RESULTS: One hundred and fifteen adverse events were reported in 113 patients (58 men and 55 women), with a mean age of 59.5 years. Cutaneous and haematological reactions predominated, with a majority of cardiovascular and psychotropic agents incriminated. Sixty-three percent of adverse reactions were serious: 49% led to (or prolonged) hospitalisation, 6% led to death, 4% to after effects, 3% were life-threatening and 1% led to congenital malformation. The mean duration of an adverse reaction was of 37.4 days. The total cost of these 115 adverse reactions was an estimated 610.110 Euros, with a mean global cost of 5.305 Euros per event.
CONCLUSION: This study shows the individual and collective extent of the impact of adverse individual and collective reactions.

Entities:  

Mesh:

Year:  2005        PMID: 15798544     DOI: 10.1016/s0755-4982(05)83904-1

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Estimation of time devoted to adverse drug reactions assessment in an internal medicine department.

Authors:  Neda Tavassoli; Haleh Bagheri; Laurent Sailler; Philippe Benkemoun; Jean-Louis Montastruc; Philippe Arlet
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

2.  Preventability of adverse effects of analgesics: analysis of spontaneous reports.

Authors:  Irina Cazacu; Ghada Miremont-Salamé; Cristina Mogosan; Annie Fourrier-Réglat; Felicia Loghin; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2015-03-05       Impact factor: 2.953

3.  Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).

Authors:  Géraldine Leguelinel-Blache; Christel Castelli; Clarisse Roux-Marson; Sophie Bouvet; Sandrine Andrieu; Philippe Cestac; Rémy Collomp; Paul Landais; Bertrice Loulière; Christelle Mouchoux; Rémi Varin; Benoit Allenet; Pierrick Bedouch; Jean-Marie Kinowski
Journal:  Trials       Date:  2018-01-08       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.